Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 60, Issue 12
Vedolizumab: what is the benefit from increasing the dose frequency?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Vedolizumab: what is the benefit from increasing the dose frequency?
Online download statistics by month:
Online download statistics by month: November 2022 to November 2023
Abstract
Full
Pdf
Nov 2022
554
22
14
Dec 2022
1143
27
20
Jan 2023
359
10
9
Feb 2023
347
4
3
Mar 2023
312
2
2
Apr 2023
92
1
2
May 2023
101
3
1
Jun 2023
67
0
2
Jul 2023
108
2
5
Aug 2023
104
1
4
Sep 2023
122
1
3
Oct 2023
60
1
3
Nov 2023
195
2
2
Total
3564
76
70
Read the full text or download the PDF:
Subscribe (£100)
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF